PRESS RELEASE published on 02/07/2024 at 16:00, 10 months 14 days ago TuHURA Biosciences, Inc. Appoints Dennis Yamashita, Ph.D., as Chief Scientific Officer and Head of Discovery Research and Early Development TuHURA Biosciences, Inc. appoints Dr. Dennis Yamashita as Chief Scientific Officer and Head of Discovery Research and Early Development to advance novel personalized cancer vaccines and bi-functional antibody drug conjugates. Dr. Yamashita brings over 30 years of experience in R&D drug discovery and development TuHURA Biosciences Dr. Dennis Yamashita Personalized Cancer Vaccines Bi-functional Antibody Drug Conjugates Immuno-oncology
Published on 12/21/2024 at 01:30, 1 day 3 hours ago Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 1 day 3 hours ago iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 1 day 5 hours ago Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/20/2024 at 23:30, 1 day 5 hours ago Boron One Announces Extension to Early Warrant Exercise Incentive Program
Published on 12/21/2024 at 00:51, 1 day 4 hours ago Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/20/2024 at 19:10, 1 day 10 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day 10 hours ago CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 11 hours ago ARYZTA AG Announces New Board Technology Committee
Published on 12/21/2024 at 12:17, 16 hours 53 minutes ago AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 16 hours 53 minutes ago AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 11 hours ago Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 11 hours ago Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 11 hours ago Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024
